Skip to main content
Signal8

Amin Dipti

SEC insider (Form 3/4/5 filer). CIK 0001856708. Director at Lineage Cell Therapeutics, Inc. (LCTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in CARLSBAD, CA.

Companies Amin Dipti has filed insider reports for

  • Lineage Cell Therapeutics, Inc. (LCTX): Director
Amin Dipti profile photo

Amin Dipti

CIK: 0001856708

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lineage Cell Therapeutics, Inc. logo
LCTX

Lineage Cell Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Lineage Cell Therapeutics, Inc. logo
    LCTX

    Lineage Cell Therapeutics, Inc.

    Jul 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    125K shares-
  • Lineage Cell Therapeutics, Inc. logo
    LCTX

    Lineage Cell Therapeutics, Inc.

    Jul 1, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    75K shares-

1-2 of 2